Listed

CVS HEALTH Corp: Form 10-Q for the period ended Mar 31, 2013

Filed with the SEC on May 1, 2013 and accepted by EDGAR at May 1, 2013, 16:41 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-01-01 to 2013-03-31$30.76bnus-gaap:Revenues
Cost of revenue3 months2013-01-01 to 2013-03-31$25.18bnus-gaap:CostOfRevenue
Gross profit3 months2013-01-01 to 2013-03-31$5.58bnus-gaap:GrossProfit
Operating income3 months2013-01-01 to 2013-03-31$1.70bnus-gaap:OperatingIncomeLoss
Interest expense3 months2013-01-01 to 2013-03-31$127.0mus-gaap:InterestExpense
Income tax3 months2013-01-01 to 2013-03-31$617.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-01-01 to 2013-03-31$956.0mus-gaap:ProfitLoss
Diluted EPS3 months2013-01-01 to 2013-03-31$0.77us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-01-01 to 2013-03-31$0.78us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-01-01 to 2013-03-311,241,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2013-01-01 to 2013-03-31$1.64bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2013-01-01 to 2013-03-31$318.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2013-01-01 to 2013-03-31$277.0mus-gaap:PaymentsOfDividends
Share repurchases3 months2013-01-01 to 2013-03-31$393.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2013-03-31$1.55bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-03-31$19.73bnus-gaap:AssetsCurrent
Total assetsAt period end2013-03-31$66.07bnus-gaap:Assets
Current liabilitiesAt period end2013-03-31$13.20bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2013-03-31$9.35bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2013-03-31$12.0mus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2013-03-31$300.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2013-03-31$38.21bnus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0000064803-13-000005. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.